Estimated use of abacavir among adults and children enrolled in public sector antiretroviral therapy programmes in Gauteng, South Africa

D Evans; M Maskwe; C Heneger; I Sanne

For full functionality, including active links, we recommend downloading the PDF. Certain interactive features may not operate within the embedded viewer.
Download this PDF file

Crossref Citations

1. Adverse Drug Reactions Among Patients Initiating Second-Line Antiretroviral Therapy in South Africa
Dorina Onoya, Kamban Hirasen, Liudmyla van den Berg, Jacqui Miot, Lawrence C. Long, Matthew P. Fox
Drug Safety vol: 41 issue: 12 first page: 1343 year: 2018
doi: 10.1007/s40264-018-0698-3

2. Differentiated service delivery for people using second‐line antiretroviral therapy: clinical outcomes from a retrospective cohort study in KwaZulu‐Natal, South Africa
Lara Lewis, Yukteshwar Sookrajh, Kelly Gate, Thokozani Khubone, Munthra Maraj, Siyabonga Mkhize, Lucas E. Hermans, Hope Ngobese, Nigel Garrett, Jienchi Dorward
Journal of the International AIDS Society vol: 24 issue: S6 year: 2021
doi: 10.1002/jia2.25802

African Online Scientific Information Systems (Pty) Ltd t/a AOSIS
Reg No: 2002/002017/07
International Tel: +27 21 975 2602
5 Hafele Street, Durbanville, Cape Town, 7550, South Africa
publishing(AT)aosis.co.za replace (AT) with @

All articles published in this journal are licensed under the Creative Commons Attribution 4.0 International (CC BY 4.0) license, unless otherwise stated.
Website design & content: ©2025 AOSIS (Pty) Ltd. All rights reserved. No unauthorised duplication allowed.
By continuing to use this website, you agree to our Privacy Policy, Terms of Use and Security Policy.

________

Subscribe to our newsletter

Get specific, domain-collection newsletters detailing the latest CPD courses, scholarly research and call-for-papers in your field.

Southern African Journal of HIV Medicine | ISSN: 1608-9693 (PRINT) | ISSN: 2078-6751 (ONLINE)